Test Price
3,000 AED✅ Home Collection Available
OncoDx Panel Genetic Test in UAE | 3000 AED | DHA Licensed Facility
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO-certified NGS processing with stringent quality controls guarantees clinical-grade accuracy.
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Hospital-grade logistics across all Emirates, available daily from 8 AM to 11 PM.
- Post-Test Clinical Guidance – Complimentary telephonic interpretation session with a molecular specialist to explain your hereditary cancer risk profile.
- Direct Insurance Billing – WhatsApp verification at +971 54 548 8731; we coordinate with your provider for cashless settlement.
The OncoDx Panel delivers comprehensive genomic analysis of 67 clinically actionable genes linked to hereditary cancer syndromes, enabling precise risk stratification for personalised screening, prevention, and treatment planning under DHA regulatory oversight.
Test Overview & Methodology
The OncoDx Panel employs advanced Next-Generation Sequencing (NGS) to examine the full coding regions of 67 clinically actionable genes linked to hereditary cancers. This single-test strategy empowers oncologists and families with precise risk-stratification data for personalised screening, prevention, and treatment. Our bioinformatics pipeline includes copy number variation (CNV) detection and variant classification according to ACMG/AMP guidelines.
| Feature | OncoDx Panel (Our Test) | Traditional Single-Gene Test |
|---|---|---|
| Method | NGS with high-depth coverage & CNV detection | Sanger sequencing of one gene (e.g., BRCA1) |
| Genes Covered | 67 genes incl. BRCA1/2, TP53, Lynch syndrome panel | 1–3 selected genes only |
| Turnaround Time | 3–4 weeks (comprehensive bioinformatics) | 2–6 weeks (often reflex to panel anyway) |
| Clinical Utility | Complete hereditary cancer risk assessment | Limited; may miss co-occurring mutations |
| Price | 3,000 AED | Variable, often 1,500–2,500 AED per gene |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403) – Consultant Medical Genetics: “A hereditary cancer panel reveals nuanced risk information that must be interpreted within the full context of personal and family medical history. I strongly recommend reviewing these results with a certified genetic counsellor or your treating oncologist before making any lifestyle or therapeutic changes. This test is a powerful risk assessment instrument, not a diagnostic verdict, and no prescribed medication should ever be altered without direct physician consultation.”
🔴 Exclusion Criteria & Clinical Red Flags
- Minors: Genetic testing of individuals under 18 years is prohibited unless mandated by a UAE court order with appropriate legal consent.
- Asymptomatic minors: Predictive testing is not performed for children without clear clinical indication and documented parental or legal guardian consent.
- Consent requirement: Mandatory pre-test genetic counselling and signed informed consent are required; the test will not proceed without complete documentation.
- Not a stand-alone diagnostic: A positive result indicates elevated lifetime risk, not a cancer diagnosis; further clinical workup and surveillance are essential.
- Emergency Red Flags – Seek immediate medical attention: New palpable mass, unexplained weight loss exceeding 5% within one month, progressive dysphagia, or severe unremitting pain.
Patient FAQ & Clinical Guidance
1. What genes does the OncoDx Panel test include?
The OncoDx Panel analyzes 67 clinically actionable cancer-related genes, including BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, and the full Lynch syndrome gene set (MLH1, MSH2, MSH6, PMS2, EPCAM). This comprehensive panel covers high-penetrance susceptibility genes for breast, ovarian, colorectal, endometrial, pancreatic, and endocrine malignancies, aligned with NCCN and DHA clinical practice guidelines.
2. How long does it take to receive results?
Results are typically ready within 3 to 4 weeks after the laboratory receives your sample. This timeframe includes DNA extraction, NGS library preparation, high-depth sequencing, bioinformatics alignment and variant calling, rigorous annotation against ClinVar and COSMIC databases, variant interpretation by molecular pathologists, and final clinical report generation with ACMG/AMP classification.
3. Is home sample collection available for this test?
Yes, we offer VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection service across all Emirates, available daily from 8 AM to 11 PM. A licensed phlebotomist visits your residence to collect a peripheral whole blood sample (8–10 mL in EDTA tubes) using sterile technique. The specimen is transported under continuous temperature monitoring to our ISO 15189 accredited laboratory in Dubai Healthcare City.
4. Will my insurance cover the OncoDx Panel?
DNA Labs UAE participates with major UAE insurers including Daman, AXA, Al Ain Ahlia, Oman Insurance, Sukoon, and Gargash Insurance. We manage direct billing and pre-authorisation on your behalf. Send your insurance policy details via WhatsApp to +971 54 548 8731 for a coverage verification within 24 hours. Self-pay patients benefit from the transparent flat rate of 3,000 AED inclusive of all laboratory processing and the post-test physician teleconsultation.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Framework
- Personal Data Protection: Your genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring robust encryption, access controls, and lawful processing.
- Health Information Governance: We adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, governing the secure storage, transmission, and disposal of electronic health records.
- Clinical Safety & Patient Consent: All testing procedures and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing informed consent, professional accountability, and patient safety.
- Quality Certification: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | OncoDx Panel – Hereditary Cancer NGS Panel (67 Genes) |
| Price (AED) | 3,000 AED (all inclusive – laboratory processing, bioinformatics, clinical report, and post-test teleconsultation) |
| Turnaround Time | 3–4 weeks from sample receipt at laboratory |
| Sample Type / Matrix | Peripheral whole blood (8–10 mL in EDTA lavender-top tube); extracted DNA or FTA card also accepted via secure medical courier. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) – high-depth (>100X) targeted hybrid capture with CNV detection bioinformatics pipeline. Variant interpretation per ACMG/AMP 2015 guidelines. |
| ICD-10-CM Code | Z15.09 (Genetic susceptibility to other malignant neoplasm), Z80.3 (Family history of malignant neoplasm of breast), Z80.0 (Family history of malignant neoplasm of digestive organs) |
| LOINC Code | 94282-2 (Hereditary cancer panel – Blood or Tissue by NGS) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians